AI-generated summary
The authors report long-term follow-up of seven patients with chronic oral graft-versus-host disease who continued photobiomodulation therapy after an initial treatment month. Oral sensitivity and mucosal changes were reported as controlled with treatment intervals of up to six to eight weeks, and the authors suggest treatment frequency should be individualized. The series is small and uncontrolled.
- Participants
- 7
- Who or what was studied
- Patients with chronic symptomatic oral chronic graft-versus-host disease
- Limits stated in the abstract
- The abstract describes a small case series of seven patients, with no control group and no stated statistical analysis.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.